Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1998 Aug 1;333(Pt 3):749–756. doi: 10.1042/bj3330749

Glycosylation pattern of human inter-alpha-inhibitor heavy chains.

C Flahaut 1, C Capon 1, M Balduyck 1, G Ricart 1, P Sautiere 1, J Mizon 1
PMCID: PMC1219641  PMID: 9677337

Abstract

Human inter-alpha-inhibitor (IalphaI) is a plasma serine-proteinase inhibitor. It consists of three polypeptide chains covalently linked by a glycosaminoglycan chain: a light chain named bikunin carrying the anti-proteinase activity and two heavy chains, H1 and H2, which exhibit specific properties, e.g. they interact with hyaluronan thus stabilizing the extracellular matrix. In this study, using matrix-assisted laser desorption ionization-time-of-flight MS and amino acid sequencing of tryptic peptides, we provide a detailed analysis of the glycosylation pattern of both heavy chains. H1 carries two complex-type N-glycans of predominantly biantennary structure linked to asparagine residues at positions 256 and 559 respectively. In contrast, the oligosaccharides attached to H2 are a complex-type N-glycan in the N-terminal region of the protein (Asn64) and three to four type-1 core-structure O-glycans mono- or di-sialylated, clustered in the C-terminal region. We propose that these O-glycans might function as a recognition signal for the H2 heavy chain. The biological implications of this hypothesis, notably for the biosynthetic pathway of IalphaI, are discussed.

Full Text

The Full Text of this article is available as a PDF (684.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balduyck M., Laroui S., Mizon C., Mizon J. A proteoglycan related to the urinary trypsin inhibitor (UTI) links the two heavy chains of inter-alpha-trypsin inhibitor. Biol Chem Hoppe Seyler. 1989 Apr;370(4):329–336. doi: 10.1515/bchm3.1989.370.1.329. [DOI] [PubMed] [Google Scholar]
  2. Balduyck M., Piva F., Mizon C., Maes P., Malki N., Gressier B., Michalski C., Mizon J. Human leucocyte elastase (HLE) preferentially cleaves the heavy chain H2 of inter-alpha-trypsin inhibitor (ITI). Biol Chem Hoppe Seyler. 1993 Sep;374(9):895–901. doi: 10.1515/bchm3.1993.374.7-12.895. [DOI] [PubMed] [Google Scholar]
  3. Bigge J. C., Patel T. P., Bruce J. A., Goulding P. N., Charles S. M., Parekh R. B. Nonselective and efficient fluorescent labeling of glycans using 2-amino benzamide and anthranilic acid. Anal Biochem. 1995 Sep 20;230(2):229–238. doi: 10.1006/abio.1995.1468. [DOI] [PubMed] [Google Scholar]
  4. Blom A., Pertoft H., Fries E. Inter-alpha-inhibitor is required for the formation of the hyaluronan-containing coat on fibroblasts and mesothelial cells. J Biol Chem. 1995 Apr 28;270(17):9698–9701. doi: 10.1074/jbc.270.17.9698. [DOI] [PubMed] [Google Scholar]
  5. Bourguignon J., Diarra-Mehrpour M., Thiberville L., Bost F., Sesboü R., Martin J. P. Human pre-alpha-trypsin inhibitor-precursor heavy chain. cDNA and deduced amino-acid sequence. Eur J Biochem. 1993 Mar 15;212(3):771–776. doi: 10.1111/j.1432-1033.1993.tb17717.x. [DOI] [PubMed] [Google Scholar]
  6. Chan P., Risler J. L., Raguenez G., Salier J. P. The three heavy-chain precursors for the inter-alpha-inhibitor family in mouse: new members of the multicopper oxidase protein group with differential transcription in liver and brain. Biochem J. 1995 Mar 1;306(Pt 2):505–512. doi: 10.1042/bj3060505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chatterjee B., Vaith P., Chatterjee S., Karduck D., Uhlenbruck G. Comparative studies of new marker lectins for alkali-labile and alkali-stable carbohydrate chains in glycoproteins. Int J Biochem. 1979;10(4):321–327. doi: 10.1016/0020-711x(79)90097-1. [DOI] [PubMed] [Google Scholar]
  8. Chen L., Mao S. J., Larsen W. J. Identification of a factor in fetal bovine serum that stabilizes the cumulus extracellular matrix. A role for a member of the inter-alpha-trypsin inhibitor family. J Biol Chem. 1992 Jun 15;267(17):12380–12386. [PubMed] [Google Scholar]
  9. Dasgupta A., Takahashi K., Cutler M., Tanabe K. K. O-linked glycosylation modifies CD44 adhesion to hyaluronate in colon carcinoma cells. Biochem Biophys Res Commun. 1996 Oct 3;227(1):110–117. doi: 10.1006/bbrc.1996.1475. [DOI] [PubMed] [Google Scholar]
  10. Diarra-Mehrpour M., Bourguignon J., Bost F., Sesboü R., Muschio F., Sarafan N., Martin J. P. Human inter-alpha-trypsin inhibitor: full-length cDNA sequence of the heavy chain H1. Biochim Biophys Acta. 1992 Aug 17;1132(1):114–118. doi: 10.1016/0167-4781(92)90065-8. [DOI] [PubMed] [Google Scholar]
  11. Enghild J. J., Salvesen G., Thøgersen I. B., Valnickova Z., Pizzo S. V., Hefta S. A. Presence of the protein-glycosaminoglycan-protein covalent cross-link in the inter-alpha-inhibitor-related proteinase inhibitor heavy chain 2/bikunin. J Biol Chem. 1993 Apr 25;268(12):8711–8716. [PubMed] [Google Scholar]
  12. Enghild J. J., Thøgersen I. B., Pizzo S. V., Salvesen G. Analysis of inter-alpha-trypsin inhibitor and a novel trypsin inhibitor, pre-alpha-trypsin inhibitor, from human plasma. Polypeptide chain stoichiometry and assembly by glycan. J Biol Chem. 1989 Sep 25;264(27):15975–15981. [PubMed] [Google Scholar]
  13. Gebhard W., Schreitmüller T., Hochstrasser K., Wachter E. Two out of the three kinds of subunits of inter-alpha-trypsin inhibitor are structurally related. Eur J Biochem. 1989 May 15;181(3):571–576. doi: 10.1111/j.1432-1033.1989.tb14762.x. [DOI] [PubMed] [Google Scholar]
  14. Gohlke M., Baude G., Nuck R., Grunow D., Kannicht C., Bringmann P., Donner P., Reutter W. O-linked L-fucose is present in Desmodus rotundus salivary plasminogen activator. J Biol Chem. 1996 Mar 29;271(13):7381–7386. doi: 10.1074/jbc.271.13.7381. [DOI] [PubMed] [Google Scholar]
  15. Hansen J. E., Lund O., Tolstrup N., Gooley A. A., Williams K. L., Brunak S. NetOglyc: prediction of mucin type O-glycosylation sites based on sequence context and surface accessibility. Glycoconj J. 1998 Feb;15(2):115–130. doi: 10.1023/a:1006960004440. [DOI] [PubMed] [Google Scholar]
  16. Huang L., Yoneda M., Kimata K. A serum-derived hyaluronan-associated protein (SHAP) is the heavy chain of the inter alpha-trypsin inhibitor. J Biol Chem. 1993 Dec 15;268(35):26725–26730. [PubMed] [Google Scholar]
  17. Héron A., Bourguignon J., Callé A., Borghi H., Sesboü R., Diarra-Mehrpour M., Martin J. P. Post-translational processing of the inter-alpha-trypsin inhibitor in the human hepatoma HepG2 cell line. Biochem J. 1994 Sep 1;302(Pt 2):573–580. doi: 10.1042/bj3020573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kamerling J. P., Gerwig G. J., Vliegenthart J. F., Clamp J. R. Characterization by gas-liquid chromatography-mass spectrometry and proton-magnetic-resonance spectroscopy of pertrimethylsilyl methyl glycosides obtained in the methanolysis of glycoproteins and glycopeptides. Biochem J. 1975 Dec;151(3):491–495. doi: 10.1042/bj1510491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kobayashi H., Gotoh J., Hirashima Y., Terao T. Inter-alpha-trypsin inhibitor bound to tumor cells is cleaved into the heavy chains and the light chain on the cell surface. J Biol Chem. 1996 May 10;271(19):11362–11367. doi: 10.1074/jbc.271.19.11362. [DOI] [PubMed] [Google Scholar]
  20. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  21. Malki N., Balduyck M., Maes P., Capon C., Mizon C., Han K. K., Tartar A., Fournet B., Mizon J. The heavy chains of human plasma inter-alpha-trypsin inhibitor: their isolation, their identification by electrophoresis and partial sequencing. Differential reactivity with concanavalin A. Biol Chem Hoppe Seyler. 1992 Oct;373(10):1009–1018. doi: 10.1515/bchm3.1992.373.2.1009. [DOI] [PubMed] [Google Scholar]
  22. Michalski C., Piva F., Balduyck M., Mizon C., Burnouf T., Huart J. J., Mizon J. Preparation and properties of a therapeutic inter-alpha-trypsin inhibitor concentrate from human plasma. Vox Sang. 1994;67(4):329–336. doi: 10.1111/j.1423-0410.1994.tb01269.x. [DOI] [PubMed] [Google Scholar]
  23. Mizon C., Balduyck M., Albani D., Michalski C., Burnouf T., Mizon J. Development of an enzyme-linked immunosorbent assay for human plasma inter-alpha-trypsin inhibitor (ITI) using specific antibodies against each of the H1 and H2 heavy chains. J Immunol Methods. 1996 Mar 28;190(1):61–70. doi: 10.1016/0022-1759(95)00257-x. [DOI] [PubMed] [Google Scholar]
  24. Mizon C., Héron A., Capon C., Sautiere P., Michalski C., Sesboü R., Mizon J. Human pre-alpha-inhibitor: isolation from a by-product of industrial scale plasma fractionation and structural analysis of its H3 heavy chain. J Chromatogr B Biomed Sci Appl. 1997 May 9;692(2):281–291. doi: 10.1016/s0378-4347(97)00012-1. [DOI] [PubMed] [Google Scholar]
  25. Morelle W., Capon C., Balduyck M., Sautiere P., Kouach M., Michalski C., Fournet B., Mizon J. Chondroitin sulphate covalently cross-links the three polypeptide chains of inter-alpha-trypsin inhibitor. Eur J Biochem. 1994 Apr 15;221(2):881–888. doi: 10.1111/j.1432-1033.1994.tb18803.x. [DOI] [PubMed] [Google Scholar]
  26. Nakatani T., Suzuki Y., Yamamoto T., Sinohara H. Molecular cloning and sequencing of cDNAs encoding three heavy-chain precursors of the inter-alpha-trypsin inhibitor in Syrian hamster: implications for the evolution of the inter-alpha-trypsin inhibitor heavy chain family. J Biochem. 1997 Jul;122(1):71–82. doi: 10.1093/oxfordjournals.jbchem.a021742. [DOI] [PubMed] [Google Scholar]
  27. Salier J. P., Rouet P., Raguenez G., Daveau M. The inter-alpha-inhibitor family: from structure to regulation. Biochem J. 1996 Apr 1;315(Pt 1):1–9. doi: 10.1042/bj3150001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Sandson J., Hamerman D., Schwick G. Altered properties of pathological hyaluronate due to a bound inter-alpha trypsin inhibitor. Trans Assoc Am Physicians. 1965;78:304–313. [PubMed] [Google Scholar]
  29. Stephano J. L., Gould M., Rojas-Galicia L. Advantages of picrate fixation for staining polypeptides in polyacrylamide gels. Anal Biochem. 1986 Feb 1;152(2):308–313. doi: 10.1016/0003-2697(86)90414-8. [DOI] [PubMed] [Google Scholar]
  30. Thøgersen I. B., Enghild J. J. Biosynthesis of bikunin proteins in the human carcinoma cell line HepG2 and in primary human hepatocytes. Polypeptide assembly by glycosaminoglycan. J Biol Chem. 1995 Aug 4;270(31):18700–18709. doi: 10.1074/jbc.270.31.18700. [DOI] [PubMed] [Google Scholar]
  31. Toyoda H., Ikei T., Demachi Y., Toida T., Imanari T. Structural analysis of the N-linked oligosaccharides from human urinary trypsin inhibitor. Chem Pharm Bull (Tokyo) 1992 Oct;40(10):2882–2884. doi: 10.1248/cpb.40.2882. [DOI] [PubMed] [Google Scholar]
  32. Witte J., Jochum M., Scherer R., Schramm W., Hochstrasser K., Fritz H. Disturbances of selected plasma proteins in hyperdynamic septic shock. Intensive Care Med. 1982;8(5):215–222. doi: 10.1007/BF01694524. [DOI] [PubMed] [Google Scholar]
  33. Yamamoto T., Yamamoto K., Sinohara H. Inter-alpha-trypsin inhibitor and its related proteins in Syrian hamster urine and plasma. J Biochem. 1996 Jul;120(1):145–152. doi: 10.1093/oxfordjournals.jbchem.a021377. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES